PathAI

About:

PathAI develops technology that assists pathologists in making accurate diagnoses for every patient, every time.

Website: http://www.pathai.com

Twitter/X: Path_AI

Top Investors: General Atlantic, General Catalyst, Bristol-Myers Squibb, 8VC, KdT Ventures

Description:

PathAI’s services solve challenging pathology problems faced by the research and pharmaceutical industry. The PathAI platform provides end-to-end automation for reliable, scalable, and cost-effective long-term solutions. PathAI is developing technology that assists pathologists in making accurate diagnoses for every patient, every time. The company was founded in 2016 and is based in Boston, Massachusetts.